{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:39:23Z","timestamp":1794778763634,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:00:00Z","timestamp":1576281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["1420040"],"award-info":[{"award-number":["1420040"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI17C1142"],"award-info":[{"award-number":["HI17C1142"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014R1A5A2009242"],"award-info":[{"award-number":["2014R1A5A2009242"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1C1B5076186"],"award-info":[{"award-number":["2017R1C1B5076186"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.asjsur.2019.12.001","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T09:28:59Z","timestamp":1578389339000},"page":"996-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of clinical features and oncologic outcomes between familial non-hereditary and hereditary breast cancer in Korean female patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Chan Sub","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Soo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib1","doi-asserted-by":"crossref","first-page":"15263","DOI":"10.1038\/s41598-018-31859-8","article-title":"BRCA1\/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.asjsur.2019.12.001_bib2","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00268-010-0683-1","article-title":"Is breast cancer the same disease in Asian and Western countries?","volume":"34","author":"Leong","year":"2010","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.asjsur.2019.12.001_bib3","first-page":"1231","article-title":"Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease","volume":"50","author":"Margaritte","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.asjsur.2019.12.001_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2407-5-70","article-title":"Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases","volume":"5","author":"Veronesi","year":"2005","journal-title":"BMC Canc"},{"issue":"9","key":"10.1016\/j.asjsur.2019.12.001_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(05)70318-1","article-title":"Familial non-BRCA1\/BRCA2-associated breast cancer","volume":"6","author":"Eccles","year":"2005","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12885-016-2962-1","article-title":"Tumor characteristics and prognosis in familial breast cancer","volume":"16","author":"Arpino","year":"2016","journal-title":"BMC Canc"},{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","article-title":"Family history and risk of breast cancer: an analysis accounting for family structure","volume":"165","author":"Brewer","year":"2017","journal-title":"Breast Canc Res Treat"},{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","article-title":"Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers","volume":"97","author":"Adem","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.asjsur.2019.12.001_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3312-8","article-title":"The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer","volume":"150","author":"Villarreal-Garza","year":"2015","journal-title":"Breast Canc Res Treat"},{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-015-3293-7","article-title":"Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer","volume":"150","author":"Wong-Brown","year":"2015","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.asjsur.2019.12.001_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2047-783X-19-35","article-title":"The prevalence of BRCA1\/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China","volume":"19","author":"Li","year":"2014","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.asjsur.2019.12.001_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J\u00a0Natl Compr Cancer Netw : J Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.asjsur.2019.12.001_bib13","first-page":"678","article-title":"Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium","volume":"52","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.asjsur.2019.12.001_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0004.2012.01859.x","article-title":"Familial breast cancer","volume":"82","author":"Lalloo","year":"2012","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.asjsur.2019.12.001_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","article-title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","volume":"100","author":"Metcalfe","year":"2009","journal-title":"Br J Canc"},{"key":"10.1016\/j.asjsur.2019.12.001_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-2407-14-221","article-title":"Prospective study of high-risk, BRCA1\/2-mutation negative women: the 'negative study","volume":"14","author":"Kotsopoulos","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.asjsur.2019.12.001_bib17","first-page":"145","article-title":"Hereditary breast cancer: clinical, pathological and molecular characteristics","volume":"8","author":"Larsen","year":"2014","journal-title":"Breast Canc Basic Clin Res"},{"issue":"7","key":"10.1016\/j.asjsur.2019.12.001_bib18","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/0008-5472.CAN-12-1699","article-title":"Genetic susceptibility to triple-negative breast cancer","volume":"73","author":"Stevens","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.asjsur.2019.12.001_bib19","series-title":"Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology","first-page":"134","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012"},{"issue":"6","key":"10.1016\/j.asjsur.2019.12.001_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2012.31","article-title":"BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years","volume":"106","author":"Robertson","year":"2012","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.asjsur.2019.12.001_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120189","article-title":"Worse breast cancer prognosis of BRCA1\/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis","volume":"10","author":"van den Broek","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.asjsur.2019.12.001_bib22","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-010-1136-7","article-title":"Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer","volume":"17","author":"Boughey","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.asjsur.2019.12.001_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-014-3167-4","article-title":"Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers","volume":"148","author":"Zugazagoitia","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"4","key":"10.1016\/j.asjsur.2019.12.001_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3892\/ol.2014.1834","article-title":"Triple-negative breast cancer frequency and type of BRCA mutation: clues from Sardinia","volume":"7","author":"Palomba","year":"2014","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.asjsur.2019.12.001_bib25","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.bjc.6602207","article-title":"Psychosocial impact of breast\/ovarian (BRCA1\/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort","volume":"91","author":"Watson","year":"2004","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.asjsur.2019.12.001_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","article-title":"Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing","volume":"118a","author":"Botkin","year":"2003","journal-title":"Am J Med Genet"},{"issue":"9285","key":"10.1016\/j.asjsur.2019.12.001_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(01)06039-1","article-title":"Uptake of screening and prevention in women at very high risk of breast cancer","volume":"358","author":"Evans","year":"2001","journal-title":"Lancet"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958419308802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958419308802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:11:51Z","timestamp":1777605111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958419308802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1015958419308802"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2019.12.001","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of clinical features and oncologic outcomes between familial non-hereditary and hereditary breast cancer in Korean female patients","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}